Single Doses of the SERM Lasofoxifene Increases Testosterone Levels for over 28 Days in Healthy Men

Trial Profile

Single Doses of the SERM Lasofoxifene Increases Testosterone Levels for over 28 Days in Healthy Men

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2015

At a glance

  • Drugs Lasofoxifene (Primary)
  • Indications Atrophic vaginitis; Breast cancer; Hypogonadism; Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top